Phase 3 Vasculitis Clinical Trials

4 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–4 of 4 trials

Recruiting

Phase 3

Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.

Vasculitis

Amgen20 enrolled31 locationsNCT06321601

Recruiting

Phase 3

BDB-001 Phase III Trial in ANCA-Associated Vasculitis

ANCA Associated Vasculitis (AAV)

Staidson (Beijing) Biopharmaceuticals Co., Ltd300 enrolled60 locationsNCT07168161

Recruiting

Phase 3

Study of Ravulizumab in Pediatric Participants With Primary IgAN

Immunoglobulin A NephropathyIgANIgA Vasculitis+3 more

Alexion Pharmaceuticals, Inc.24 enrolled14 locationsNCT07024563

Recruiting

Phase 3

Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisEnd Stage Renal Disease

Centre Hospitalier Departemental Vendee136 enrolled58 locationsNCT03323476